PRA Health Sciences (PRAH)

Tom Byrne VP, Legal Affairs
Colin Shannon CEO
Mike Bonello CFO
John Kreger William Blair
David Windley Jefferies
Donald Hooker KeyBanc Capital Markets
Jack Meehan Barclays
Juan Avendano Bank of America
Sandy Draper SunTrust
Dan Brennan UBS
Erin Wright Credit Suisse
Call transcript
Due to licensing restrictions, you must log in to view earnings call transcripts.

Good day, ladies and gentlemen, and welcome to the PRA Health Sciences, 1Q 2019 Earnings Release Conference Call. [Operator instructions] As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Mr. Tom Byrne, Vice President of Legal Affairs. Mr. begin. may you Byrne,

Tom Byrne

and Good PRA thank of Health Colin quarterly Executive Teleconference. you. Officer, Chief us discuss will XXXX for for Today, our Officer; Chief our the Sciences results. Shannon, Bonello, morning, Thank our you Financial and financial joining Earnings Mike Great. First Quarter

will comments, Following for our we opening questions. available be

Relations addition is available information to additional with financial our In website. the press portion Investor supplement our release and investor of in

due our to those remarks like the February XX, include included statements I'd we are implied that questions results factors in which remind Before risks by our XXXX. responses Annual SEC to business, may on Form and you forward-looking and with associated may our Report in begin, to filed differ risk stated with forward-looking discussed Actual statements. materially from the or on uncertainties XX-K

call how our and press CEO, financial Relations to website. Investor in views accordance earnings assume GAAP, to with included financial reconciliation any measures helps consistent complete with of GAAP our the the our A Our Please a will believe with calculated note Shannon. financial supplement risk now non-GAAP management gain time measures non-GAAP financial release presented and this I to factors discuss we results our available in like these providing to that is and in these and We portion obligation investors more Colin comparable our time of we may on understanding results. updated financial call SEC. the statements. turn helpful measure, the from Certain no are to measures. most investor is of would the filings over in be that measures forward-looking update

Colin Shannon

our happy that first for XXXX that and you call solid on you, were results in I delighted ground our quarter our am financial the line expectations. thank conference Good and morning, to have covering we started first with Thank quarter joining report results. Tom. financial off

expand $XXX of representing Our times net financial net margins metrics business revenue. to continue awards, adjusted XXXX, Continuing and X.XX X.X to new quarter income to income we revenue. the grow adjusted share to of at than In improve net book-to-bill we net diluted of continue per quarters our operating continue book-to-bills double-digit rates. first as net our a of million run times reported or greater our equal with and

that of discussed, award backlog new of year-over-year, concentration revenue. increasing approximately Solutions previously well awards to does our in As a $X.X the have and our Data be excludes sector or new coming and sector. and billion. continues our Please on book-to-bill reimbursement of our at finishing not segment. from awards segment XX% we The awards The our reimbursed the net XX% addition from Solutions revenue our quarter X% coming biotech with business diversified and approximately approximately Data remember our include pharmaceutical business of our first sequential XX% new basis calculation revenue approximately from backlog business resulted new has

remains that that seeing Although not certainly of quarters of quarter reflection is CRO the sector. it add pharma, with what a line more the towards was of we overall previous the stable. and seen not far first we XXXX in have would weighted I biotech are heavily what environment out in

changing But to point, as slightly industry for with see proposals trial Medicare RFP be the we to the clients be continue of all. impact X% design exchange on the clients steady this currency but at led exchange quarter has foreign volume, also final path, X% an to basis. Total revenue approximately slower start continue erratic around development was of on year-over-year awarded we times. a rates once the to to approximately which Revenue not and the appear There continues such rates basis. represents actual million the assessing pharmaceutical increase are $XXX taking still X% previously which at actual noted programs. these longer we for first a and proposals see to are are year-over-year constant revenue growth constant flow X% at of We currency determine foreign a and business, and was excluding that approximately do reimbursement

first within range we February. provided the was guidance revenue Our quarter in

reimbursement to of period-to-period try continues However, we team versus continue in and volatility. recognized expectations. process our look in see forecast been to volatility at The resist to our revenue of this has retaining to amount that ways

has an revenue million $XX been Adjusted that will recognized of future. XX% the the of recognized be increase in of quarter be and in types be to a that of and we awarded activity for factor revenue of quarter income versus part are of the the net the studies first that However, XXXX. amount was approximately the managing in amount continues presence that main will our customer’s we approximately

While $X.XX, of adjusted net a quarter increase versus first diluted the income was XX% per share XXXX.

our client our approximately approximately clients the client continues Our largest to revenue diversified XX% five representing well X% revenue. of of reimbursement be metrics for top base exclude with Both representing revenue. with quarter

annual week payment Data Regarding and in made final of was Symphony quarter, first April annual the as our XXXX. concluded I segment, for mentioned Solutions payment we last the the

culture changes leadership appropriately the to the to quarter, align made and vision I PRA. the larger During more

our the expected at in quarter. approximately end very million great organizations strong leadership less the unfortunately range very have We it PRA the caused to talent us expected a larger the received. was This been be million for having revenue $X.X than this has ties lot $XX.X and distraction to that well segment and lower with of of at

our team business offerings look now the process in in integration by get full it the strength of and out expansion. new building to more commercial are investing continue We to we international to evolve and

their will $X.XX our share. entire diluted between will and our our reaffirming for continued reaffirmed like PRA provide I more share, hand for who and Officer, now positioned go the the solid about per Health XXXX in XXXX well guidance thank is start, Mike off In to Sciences. our results through details call. $X.XX clients the are mentioned financial we year. to $X.XX staff adjusted XXXX Chief of closing, believe remainder I’d additional share a As the and I in call be release, expectation Mike an later our in Financial detail. would per we per with over and to like our earnings to press the commitment Bonello, to are guidance, sorry will quarterly

Mike Bonello

Good Colin. morning, you, everyone. Thank

revenue rates on a quarter reported XXXX, X.X% of constant grew first XXXX first revenue the foreign reimbursement to basis. approximately $XXX guidance, $XXX.X million million. of foreign for negatively than revenue first We currency X.X% of When $X currency compared XXXX. first consolidated lower impacted of to our was the by For approximately exchange fluctuations for revenue by and our by forecasted compared reporting the quarter $X quarter at million actual and quarter million

a XX% Our XXXX came of actuals XX%. reimbursement assumed while in approximately service revenue, guidance at of revenue

for the for no earlier, Solutions timing we in segment. Clinical Data the As in mentioned XXXX million was million and Colin for on by has this $XXX.X Revenue of purely quarter. reported difference first the Research segment impact quarter $XX.X the segment rate related earnings the is and

revenue quarter an quarter due is Clinical rate staff. SG&A for line in direct The our midsized of compared quarter of from expenses XXXX. of revenue first companies, and from the from XXXX first slight pharmaceutical staffing by metrics hire pharmaceutical direct our to costs as XXXX. XXXX. quarters. the XXXX of all in previous small in the compensation. Data in of SG&A to earlier primarily direct exchange of revenue companies. Direct in as from biotechnology a first were fluctuations, continue favorable was were XX.X% was as in or segment Total revenue The decrease currency million biotechnology exchange exclude primarily of to primarily companies, in XX.X% for increase These large quarter concentration quarter reported and million large with first related revenue an to utilization the rate the are of in to the derived the first currency of our costs of levels. which of from quarter to XXXX, increase we discussed $XX.X in $XXX.X were revenue and $XXX.X what segment $XX.X Regarding concentration XX% expenses the foreign of first percent to to companies, in cost in service reimbursement first The fluctuations XX% Research increase increase of stock-based compared revenue of XX.X% ensure favorable other for we decrease in million to our XX% in XX% Solution a labor-related related XXXX percentage offset an million is impact the cost XX.X% quarter compared and we cost appropriate

in certain whose first XX.X% changes quarter of $XX.X fluctuation our per quarter of compared XXXX in the quarter working share increased to cash saw increase we results, per flow income, is increase Adjusted diluted operations first increase net for from annual to the in expense previously quarter with which is to in necessarily As an $XX.X in does increased our result stock-based employee items to per operating Cash the initiation compared million $XX plan XXXX, was $X.XX consistent XX.X% capital. period our of the first net million quarter the of and the the stock fourth a in XXXX. income our to expansion in grant million XXXX. the offset of to Adjusted excludes $X.XX share period trend the XXXX. operating first by discussed, of in share purchase first of provided program was operational of not by performance, related The quarter grew in of compensation XXXX. and to the correspond

$XX.X was outstanding quarter days net XXXX, Capital sales XXXX were million in expectations. of of XXXX, with XXXX. March to first million at line quarter days our and the for expenditures XX, compared the and Our first was $XX.X for XX

our the support reflect to continue expenditures capital technology expansion in information infrastructure growth. Our our to our investment and of

cash $X.X March balance March $XXX.X March by was at outstanding XX, foreign cash debt XXXX at to our $XXX.X equivalents debt was less XXXX. XX, million Our of as XX, which cash and compared subs. defined held at million billion XXXX, million was total $XX.X Net

were dollars, reimbursement XX% excluding prior revenue with revenue consistent expenses, which expenses were while U.S. XX% with denominated in our is of concentration our of on total in quarters currency and levels. denominated Regarding dollars, XXXX consistent U.S.

continues Our to exposure euro be hedged. naturally

we discussed in GBP. in to X% of GBP exposure prior in our than of movements while have GBP are was dominated revenue X% as denominated the approximately have in quarters, expenses we As less our

as representing in earlier of billion, guidance XX%. growth is call, the to reported referenced between constant revenue company currency Colin in $X.XX X% XXXX As the and billion of its reaffirming $X.XX

XX% reaffirming and share We are representing net adjusted and our per net and between XX%. $X.XX per share income $X.XX GAAP growth $X.XX of also to $X.XX diluted of diluted between income

rate And of questions. We continue as and euro And when asking All the X.XX January XX, Operator, changes we as GBP annual previously regulatory in assumes your the estimate income Act. to That things, estimate we're your rate guidance among open and differ our and may a you to, allocation Cuts geographic due includes affiliation name our happy as other XX%, at now the Act. the Jobs question. XXXX. to remarks. which tax effective of that Please prepared from guidance U.S. foreign the in expected line. Cuts X.XX. other our rates Tax U.S. provide from impact related Job and our note may your of our currency as pretax to this concludes have discussed, Please the income agencies changes now tax take the of of are exchange rate rate effective well Tax


John [Operator from Kreger William instructions] And our Blair. first of question comes

John Kreger

going you three I'm right, and the How guidance for whole are implies high I the the think growth driver math doing the of do given that key side maybe improvement Data feasible think that, is And comfortable If the Clinical to quarters. or single-digit slowdown your year next the Research for low be revenue your digits year? you more double on over Solutions? is last in the

Colin Shannon

when is our by from of a John, of end question. have -- year we got this so visibility the the very good coverage, for the modeled we've backlog driven backlog. lot Thanks the we

all up we're hiring, it. And these we're get and So clinical won getting last seeing the -- rapidly to to mentioned and build meet operations numbers. feeling feel the we're quarters And because ramp quarter, number -- last out over that ramp mean, are our pressure we from staring -- to up. of can obviously I we've studies starting confident order already of to we're the I in

PRA We're the bit unsure the I'm So all the traditional mentioned how very that confident to big areas over. things and the And that. a cetera that government the up because are solutions. they with are that we're changes overall, noticing already little watching they they’re that savings we’ve about going react evolve. feeling we’re in – started piece et pricing and everything strategic the on about pharma We nervous like with cost and their tightening and

amount So don’t huge of I see there. a growth

expect is, Data part as we major feeling coming Solutions We’ve feeling latter up. is now. you part it’s ramp slow see business. the a from back-end year. pretty leadership be QX, the so a our good So we’re it know, fairly traditional but bit of the to May a good the rest still of of A of about new loaded got little we it pretty in

Mike Bonello

just the the midpoint. kind just add FX million what into out, John, And – and movements XXX from we from historical within, we point had after revenue, $X account budgeted were I’ll the regarding of taking

the there’s portion of not the really the later of out being us towards pushed range was a significant component. pass-through like lower it’s being into amount the QX biggest for So quarters end

John Kreger

just And Symphony. follow on one Thanks. Understood. up quick

call that that the internationally. mentioned and to time last You too opportunity a on nice you think I see business expand

of that margin? a a If we from about or is Symphony term build thinking do you less near it, Thanks. as as pressure that contribution you maybe out? do on the going bottom-line that to be you in be Should

Colin Shannon

at our a as the this, and really there the us getting pricing. is looking on our that are I mean, -- know of clients right we offering for there’s we John. Well, how really of right just to potential the it assets so depends it’s a improve manage Because demand lot

we are So, many opportunities evaluate and to looking here.

to do that new clients more. as the positive feedback love out would a of say to a I really been they to us delighted The our strong. clients, others. think has offering, good and us are the that has been see really, viable something number that very it’s things to They leadership

out make we’ll think So, we But, because part we there feel feeling expand we what, a in short-term like do actually -- from of the investments the of positive it. name it I’m I’m very longer-term willing longer that most and we if can good recover to these about other sure very the I parts cover business. make the


question David next Windley our comes from Jefferies. And of

question. proceed your may You with

David Windley

could Thanks. the more -- on factors Funding? for in are and are are Colin, elaborate bit what regulatory Thanks. the a your segment you more And client are is which example prevalent? design? of the influencing What influencing qualitatively these study base that factors protocol that that starts that? those little delay

Colin Shannon

Well, I’ll remove at an funding all. because issue that’s not

sure finances all that to cover an always make the always whole vetted. well including fundings, we award are have of accept grants. they study investigator our Before the we even we’ve very our And clients checked the

when quarter, concrete last when start in this still of finding share signing, as over to summer. by is I opportunity we We’re we’re awards this, to And study why said, that looking we’re is looking quarter, various get been benefit. affiliations Mike of out last sliding to a the this everyone on design. at and start happen this as really and multiple the how appropriately which and mentioned I of since a we million bit. mentioned that we was that we’re in right just get optimize protocols going million But, -- as and $X type cost we’re mentioned It’s balance our little identifying went direct scenarios and business. rebids a for $X.X remarks, getting that out and when this prepared exactly the seeing doing we’ve Solutions country we see included Data it that my more shortage taking our knew more what at mix I in

at everything So sharp we heart. revenue, except are confident actually and it's pain feel pretty -- about we the honestly, reimbursed this

David Windley


that. Okay. Appreciate

as the recompeting about So clarify, that activities, but you're the to for opportunity client maybe I not these think is business, evaluating strategies, correct? rebid and -- the thinking

Colin Shannon

Correct. Yes, this after is award.

David Windley

Right. Right.

a whether or not business the you keep question So not.

Colin Shannon

new or all analytics take we This using venturing. that actually, you then through new and data back wasn't But it No. it Correct. giving of is anything No, anything is never lot -- mean we're formerly would I -- the awarded. we give go as options, a our approaches, just takes it to get new in, hone We to bit and a them want opportunity a in is just opportunity client of and longer. done. ideas really lot they it what an little best really giving

David Windley

segue and the them more that because to minds the a And in Is that's industry of that I insightfully are is for into tools on are today? think? lines going good the up maybe to a which this, of do clients' you strategy is activity these tools, or going you're data more analysis example, ask, bear, is being front do to along that open that the what contributing to on lot that or intuitively was of selling bringing to study -- allowing now think

Colin Shannon

really uptake would It's varies. say, partly. the I

what's clients process. others going very sophisticated the And to thought got on they market do. that are in -- our to patient know place, population choose traditional decide we and happening understanding we very are data high-end You've wanting in users more who and of want with what what's the the

them, there whatever are we need. support aspect to help they with them We

trial that so will use really goal faster help to continue them educate capabilities to them is Our cheaper. the get and allow done and to our


Hooker Markets. KeyBanc Capital question of next your And from Donald comes

Donald Hooker

segment, year this Data for you and clarify baked have guidance with revenues? regards into in maybe So to what help terms of Solutions the

Mike Bonello

haven't point. we it that that is, we of at change estimate with and Donald, disclosing We're this we that fine-tuned have disclosed want still to -- at this what management, be sure make won't the we point.

Colin Shannon

have had Don, mean, is we've planning had what sessions. I we actually

commercial force, we're creating a because are to sales -- was our sales bit We little our building adding on depleted. out we're force, it

We're at creating and work and new client offerings. PRA to that's We're to get to larger continuing looking at data continue the new We We're We're more looking with looking elevate service are international closer opportunity. offerings. offerings. needs. organizations, looking

the direction at about we're going in, what convert not with So we're have on into exactly it's locked to point, excited we where this but going to numbers.

that At line to in the the where off have year, said felt always that a we We that we'd though to digits be would grow aiming. it's aim rocky this point in quarter start. going first still and little of even always business other I with be parts low bit we've double have got

Donald Hooker

That's perspective. Okay. Research the helpful maybe switching segment. And then to Clinical

recruiting Just pretty of to -- from you your staff business new won. I aggressively you're that that understand kind commentary backfill

sort about, I margins, So see XX margins gross a at months? to but seeing I sequentially we gross when there think guess where little of a you of, are down trending in, bit sort we're pressure high over staff new brought sort next the are watermark? probably as forward? you XX of of Kind we do going

Mike Bonello

think margin expansion into I forward our see with of hiring and baked hold Yes. think where hopefully the end gross No. year. I some margin were towards and -- the should forecast higher first expect to going line have quarter. in that obviously the We some they don't our utilization

Donald Hooker


Now real and then I off. quick jump one, just one last

was there of is a bad in But In a not I for what necessarily backlog focus terms backlog -- it terms burn low burn watermark in also it's a our and shift mix there bottom sort terms percentage? obviously Or so the of is in there understand burn? backlog is of thing. just a there of

Mike Bonello

in So for presentation, we slightly our see was least backlog first XX.X% burn, quarter what what at the had that -- our above and for quarter. was as you investor forecast the just

that and starting but were get in we'll the -- feeling don't we're trough we to hit levels more turning previous seeing in know increase bottom be should like an should the of rate. I it to out years, that we I'm the So burn where -- back of start towards


And next of from our question comes Barclays. Jack Meehan

Jack Meehan

in growth get that the bit meaningful the the XXXX was off build maybe with just more think some to burn see the Do you -- a sequentially possible to little throughout you Just it's year in to clarification outlook. quarter? expect you hoping more of a on pick rates could or up pickup the actually that, up do step

Mike Bonello

line the year. end quarter the first where same. probably should relatively I towards we're And think pickup of rates those the so see be with for be quarter, we'll we -- second back the the in were be more the in

Jack Meehan

obviously, give makes And was the customers you I That one mark-to-market closed. hoping your sense. deal could with then, of us with a Takeda, larger

the there curious of terms awards closed. taking Just dialogue's what Shire what and seeing about is been the the you're potentially some deal now in of share,

Colin Shannon

there's are know Takeda You evaluate they work a steps. as being performed by lot group next of the with teams the looking our intense to

that we workers We -- the lot moment a nice have doing at with, mix strategic what just obviously, are other with are of working a of they're CROs book business just they a there's in with there's right obviously and sold have going our forward, rationalize continuing a walk and us now partner, to Shire. main trying through how be are to but there to going we got internally,

and So amount -- have to relationship It's needs. if them huge that's them support future things enjoy activity. able continued getting that their to then we of we organized obviously the just a be collaboration's and in we've help --


America. next Juan of Bank our of question And from comes Avendano

may question. with your proceed You

Juan Avendano

EBITDA some given Can the on business When incur. Data were that adjusted and you. acquired the an the to that Solution low nowadays? you Symphony, Hi. margins I Thank had you margin give adjusted believe business of costs for us implementation investments in EBITDA XXs you update

Mike Bonello

in manage you business margin. the manage disclosing We don’t or you’ll only see our look that to XX-K. disclosures the not gross to as to information. we’re Juan, business We that anymore back if extent that

being other that is are businesses. both in costs shared by there obviously there So

accurate So number. an give me you to wouldn’t allow

Juan Avendano

follow Okay. know And competitive due my unrelated. to flat more shed on I dynamics, hiring this? Can again. this your of back Is year-over-year. you growth But any gross up light you’re capacity, wins was up lack

Colin Shannon

That’s definitely competition. a stronger

aggressive, no reason always is pricing There’s we’re it are finding in particular appropriate. that always way regarding say rates one for felt that We’re particular we’ve we we to pretty a that as everybody keeps -- be on that any would losing reason. market look

it of as as maybe risk bit Sometimes associated a at looking you get with are -- strategies we A first. pricing the our closely little and lot of understanding is, it data it. at

like we're what us we rest. to good to can So, we’re the priced And that study take this is a to of feel understanding in lead we’re sometimes being studying getting the yet it higher going following preceded appropriately. price

that’s that a about the where there. We’ve at can is out service the go diversified all winning be we volume dynamics. to business this the manner, I to client And of and positioned. very is explaining just share mix there dynamics pricing that it amount and competitors, data, seems moving it say lots very, we’re good we’re RFP to of because great feel though we’re reason looking of client very our that we’re So supporting everybody's that are showing a And is a around business. an got good good at off

Juan Avendano

Thank you.


Thank And from comes our Sandy Draper question of you. next SunTrust.

You your proceed may with question.

Sandy Draper

of a Is business then number denominated Did Or missed a growth that Data around maybe business And Solutions? give may just in currency, couple and there Solutions? a up. is dollars? for Data excluding Thanks currency constant U.S. any Jack just you guess, it. first, of for I the questions impact on maybe FX XXX% follow I research very have much.

Mike Bonello

it didn’t I out, gave total. in to I you just break it

I’ll all So is Data Solutions segment this tell that the you U.S. dollars.

think there, I dollar you piece can Sandy. figure So, the out

there about impact in about respect versus where to was from said what to versus came actuals we -- $X a a with FX had guided like I revenue. So, million

Sandy Draper


there terms for about in of the and maybe you it Colin, I Got of or weren’t there change has think shortfall Data didn’t -- the helpful. something cetera. just to market So out there? your the you That’s is happen happening things, the were the as Okay. is wasn’t after? it You focus of enough in seeing understand it. is Solutions. something The go were refocus competitively? in you is in When winning trying this how -- opportunities that terms control think to et opportunities? I’m just opportunities? much not management And I the versus change

Colin Shannon

This no. I take later [indiscernible]. total in was changes all on the make February. I in because couldn't Oh, -- of And responsibility

needed and add and I force prepared was to to leadership aware in adding the sales that everybody appropriately. selected So we're place, I we that got made and I our new wasn't start to until how sure and aligned

to working lot very But managing use feel service over And others was well. be depends that with varies the but it's good. said kind of paying that another really on So business lot and to pretty was of of well as going have and I was that's to streams respect lumpy what there's when year, they actually about the the directionally going in we're how clients. now use starting actually part. What had estimated to all I But did, cost we're revenue component, And so it kind, are it's well value overall, that a kind it. forward. which we're done, is good but service more. it aware that down and it in uncontrollable the it say, was The that's with, to new actually going consequences. I a -- we I thought enough, because


And our of question from next comes Ross Evercore. Muken

Unidentified Analyst

this Ross morning. on Luke It’s

opportunities where an pharma have completely presents working it of up to opportunity indications kind and follow one, And times. that that and this to new these you therapy layer the -- on and of Is of on quick cell gene slower due a therapy thought also function a a this be prior data. -- any start could Greenfield experience? don't on also you're train have client Just Dave's of like are more the so with

Colin Shannon

Exactly. populations studies tactical with as best Exactly can and well, them. where go the It of happen the complex lot how patient we a case. after

them the really the a best client how So course, identify trial with help optimize been patient once we've population them to to to the success of the are forward or study. to ensure where selective locate what what really looking looking and at

Unidentified Analyst

about And Great. up on I that guess Solutions the investments running. then talked Data you back to get the Okay. that and for

offerings of management's Now what force, Just expand place, upon? technology of extra in the kind give on cetera? kind new that and us are of besides an idea that innovation you et sales looking to bill, guys

Colin Shannon

you at looking. any mean for those our more the our always And more marketplace. this looking capability the we're get in clients to analysis clients the data more who'll help to lookout we for gaps. they're new realize to us look done, sources understand point, to you start for a have, in are I give what Well, --

saying, client's So where companion what So for do context reconnect? that at together? we more offerings, data ways are well, we're data looking analyzing for. do when there that new new meaningful looking we're the How new it give blend the to we what How looking get do of sources? we helps

move forward. We've -- there's do the important overseas capability. So capabilities attribute. the One was to and then up obviously, help the that's able to weren't that infrastructural privacy that infrastructure of overseas something invest an thing and, to we got all

as -- so make meaningful that forward, So opportunities we're a right we we sure manner. progress looking that do we the in for now to

Unidentified Analyst

that a would just what you So, have. of complementary be it's finding dataset already

Colin Shannon



Dan from of comes question next Our Brennan instructions] UBS. [Operator

Dan Brennan

of from I may political Colin, earlier made about headlines comment these drug be -- from all the to like to you wanted Q&A Medicare a for at the pricing. the influence go back or kind potential behavior just in

this related you at established like, point. companies like can on potentially or on, is I more and First, not like, you secondly, seeing? clarify more You wanted just impact are this could to some mostly what hesitation to out something controls just the mentioned cost just biotech? the clarify, pharmaceutical And you emerging flush

Colin Shannon

been we've the the pressure getting watching that Well, the are that continued looking with gains, that, procurement impose. get stuff but lot costs a more sector seeing continuously less. to there big works not pharma they're the and and budgets ones looking constraints that at our productivity with very closely deal with they've they any division and more partly, looking pharma like we're Strategic Solutions they're development And for altered costs impacted at for primarily,

So to the and get they that that's their doing. feeling and are of up spending definitely they more trying shorting are definitely trying to cost their we're currently watch what structures value

other parts them delighted the with our we're support to the in that them and productivity. clients working help business some improve of achieve we So with obviously and help that be of our the utilizing helping to opportunity tools have

we're -- some So but certainly on feeling marketplace. there's there what's going of angst the that in because

Dan Brennan

the just just competitive And on Great. other one environment. then

pricing also stronger changing. necessarily think you but mentioned guess, But competition. fair, I mentioned is not you I maybe always, seeing it's

So is just there that any environment of the change to overall as in want out flush competitive that alluding you're I well. kind point to.

Colin Shannon

to stabilize. starting stronger of lot CROs a think entering mergers are are have the in as Obviously they I position. been the a

So to are I that more lot getting much it's fair that more and focused attention. a say think they

changing. service make It's teams. that project strong our and got improve capabilities, been enhance offerings, service always our because IT of for there's continuously our developments And data see always to just So and majorly anything prevailing we competitive players our support more out we're to use working continue I don't on there.

way. of charge are destiny, in we we own So sure the make lead charge in our we our own


Wright And comes from our Credit next question of Suisse. Erin

Erin Wright

dynamics you any trend. the demand quarter? had just flow, could unique in across of fluctuations of on comment the I insourcing, both at versus broader kind general relationships full any if RFP FSP Great. of specifically outsourcing question you in going just seeing kind the sort all a going on. see And service then in forward? kind potentially What on you of Are

Colin Shannon

it’s point, assess how Thank hard a may definitely than you bit been we’ve that that and that. based flatter But be at seeing Yes, to it FSP we’re certainly and still the and We're -- but our traditional we’re just work, for previous strong forecast from we're little opportunities type that. building about element. the cautious on seeing this work project temporary years.

are we’ve a well I we of some do we think lot What And out building as type et as continue take we we trend. forecast. FSP effects? So a it to of covered. our the of how preparing got cetera, would out looking guidance are the pretty mitigate that caution So, for we’re


Donald Thank Capital from comes you. KeyBanc Markets. question next And our Hooker of

your may with You question. proceed

Donald Hooker

great. Hi,

follow up. Just a

about assume One the of bit looks the forward. balance like CapEx? questions elevated down I you’re sort about going think of think meant quarter. to and as it we sheet paying ask was as looked we How It do a little was I debt, the -- great I in mean,

head I just a CapEx what as I to want should changes the of company. be sure So, you’re making spending with lot get around make

Mike Bonello


I in Don. I to is think -- this our it call, referred February I think

has be I that, be able that I those some it my say get the been staff think the anticipated were to roughly just remember prioritization spend weren’t of I higher had but than to number of $XX We the to higher. want roughly money last $XX don't top historically off $XX around million would year. we because it that projects million going to head, million is of We year done. last to in

I will projects be us year expect last of the and were some slightly year cause push will we missed this So, to try that XXXX. to higher into wouldn’t that in that

Donald Hooker


would then, And maybe kind of like that more a So bleb. guess, a I thereafter normalized trend. be

Mike Bonello

correct. That’s

those still what of -- So total we in would at in total two XXXX we’ve and looked spend and I years. kind would at in looked spent have we XXXX

will done, when the same. be So, everything it about and said

Donald Hooker

That’s fair. much. Thanks so


to over I Thank you. showing CEO remarks. back turn would for to at call Colin like now any questions And this Shannon, any I’m further the further time. not

Colin Shannon

call everyone you, participating in today. thank our Well, for

additional any to have very feel a you hope us. have the questions, We free rest Thank you day. If of you contact great please much.


Thank you. conference. And all Ladies today's and you program. participating wonderful gentlemen, day. in does Everyone, disconnect. a have may today’s you thank conclude for This